Health
FDA Approves Landmark Pancreatic Cancer Drug Rasonque
FDA approves Rasonque (daraxonrasib), a first-in-class targeted therapy that nearly doubled survival in metastatic pancreatic cancer patients.
—6 min read
Tag
#Cancer Treatment
5 articles
HealthBusiness
Moderna Surges After mRNA Cancer Treatment Passes Trial
Moderna and Merck announce their mRNA-based cancer vaccine intismeran met key endpoints in a Phase 3 melanoma trial, sending Moderna shares up over 120%.
—6 min read
Health
Ifosfamide Shortage Forces Doctors to Scramble for Care
A nationwide shortage of chemotherapy drug ifosfamide is forcing US doctors to ration supplies and seek alternatives, exposing supply chain flaws.
—5 min read
Business and Economy
GSK Acquires US Cancer Biotech Nuvalent for $10.6 Billion
GSK announces its largest-ever acquisition, buying US cancer biotech Nuvalent for $10.6 billion in a major oncology push under new CEO Luke Miels.
—4 min read
HealthMedical Breakthrough
Experimental Pill Nearly Doubles Pancreatic Cancer Survival
A new experimental pill nearly doubles survival for advanced pancreatic cancer patients, targeting the long-undruggable KRAS mutation.
—5 min read